C ontinuous peripheral nerve blocks (CPNBs) are relatively simple in concept: a catheter is percutaneously inserted adjacent to a peripheral nerve, followed by local anesthetic administration via the catheter (Fig. 1) . Thus, the terms CPNB and "perineural local anesthetic infusion" are often used synonymously. Using currently available long-acting local anesthetics, the maximal duration of a single-injection peripheral nerve block is 8 to 24 hours. Therefore, CPNB provides an alternative option when a prolonged neural blockade is desired. 1, 2 Since its first description in 1946, 3 CPNB has evolved from an experimental case report involving a needle inserted through a cork taped to a patient's chest, to a well-validated analgesic technique accepted by the medical community with products designed solely for its application. This article is an evidence-based review of the published CPNB literature.
INDICATIONS
The earliest reports of CPNB describe prolonging intraoperative surgical anesthesia 3, 4 and treating intractable hiccups. 5 Later articles report using CPNB-induced sympathectomy and vasodilation to increase blood flow after a vascular accident, 6 digit transfer/replantation, 7, 8 or limb salvage 9 ; alleviate the vasospasm of Raynaud disease 10 ; and treat peripheral embolism. 11 After trauma, CPNB can provide analgesia during transportation to a distant treatment center 12 or while simply awaiting surgical repair. 13 Although yet unvalidated, reports describe CPNB to treat chronic pain, such as complex regional pain syndrome, 14 intractable phantom limb pain, 15 as well as pain from terminal cancer 16 and trigeminal neuralgia. 17 However, the overwhelming majority of CPNB reports involve the perioperative period, and only this application of perineural local anesthetic infusion remains validated with randomized controlled clinical trials (RCTs). 18 Because there are intrinsic risks with CPNB, most providers restrict its use to surgical procedures that are expected to result in pain not easily controlled with less-invasive analgesic techniques (e.g., oral analgesics, cooling/heating pads) 19 or in patients with an intolerance to alternative analgesics (e.g., opioid-induced nausea). 20, 21 The surgical site dictates the anatomic location of catheter insertion (Table 1) . Although not as thoroughly validated as in adults, CPNB has been described in hundreds of pediatric patients. 14, [22] [23] [24] [25] [26] [27] 
CATHETER INSERTION (NERVE STIMULATION)
Historically, perineural catheters were inserted using induced paresthesia, 3 a facial "click," 28 or fluoroscopic guidance. 29 However, after the introduction of portable nerve stimulators in the 1970s, the overwhelming majority of published CPNB reports involve this modality. Originally, this technique involved using electrical current to place an insulated needle adjacent to a peripheral nerve, followed by injection of local anesthetic and subsequent perineural catheter insertion. Although multiple prospective studies document the possible high success rate of this procedure, 30 -33 others have found an unacceptably high rate of "secondary block" failure, 34 presumably when the catheter tip was unknowingly misplaced during insertion. 35 To help counter this risk, the perineural catheter may be first inserted, followed by a local anesthetic bolus via the catheter itself. 36 -39 However, remaining unknown is whether a relatively large bolus of concentrated local anesthetic resulting in a successful nerve block guarantees that the catheter tip is close enough to the target nerve(s) to provide analgesia during the subsequent infusion with relatively small volumes of dilute local anesthetic. Regardless, even if prediction of successful perineural infusion is provided, the identification of those failed catheters requires waiting at least 15 minutes for block onset/failure, followed by removal of the catheter/dressing, repreparation, and catheter reinsertion, a process requiring a longer period of time than many practices permit. 40 In addition, a partial block is possible, suggesting the catheter tip is not optimally located, but often precluding replacement using electrical current.
An option is the use of a "stimulating catheter" in which an electrical current is used with an insulated needle to locate the target nerve(s), followed by the insertion of a perineural catheter that conducts current to its tip. 19, 41, 42 If muscle contraction intensity decreases during catheter advancement, it is presumed that the catheter tip is moving away from the target nerve. 43 This provides real-time evidence of catheter-nerve distance. 44 There are data to suggest that in the area of the popliteal fossa, using stimulation during catheter advancement results in the catheter tip being placed closer to the sciatic nerve. [45] [46] [47] [48] Although there are limited data suggesting a similar improvement for femoral and interscalene catheters, 43 ,49,50 the clinical relevance is questionable for these anatomic locations. [51] [52] [53] [54] [55] [56] Unfortunately, continuous muscle contraction guarantees neither surgical block nor postoperative infusion success. 43, [57] [58] [59] In addition, adequate muscle response cannot always be elicited with catheter advancement 43,59 -64 ; and stimulating catheters take more time on average for placement and cost more than their nonstimulating counterparts, 48 ,65 leading some to question their overall benefit.
66
There is minimal, 67 if any, benefit of injecting fluid via the needle before catheter insertion to "open" the perineural space, 68 but D5W is recommended if a bolus is used.
69,70
Lastly, there are few data to provide recommendations on the minimal acceptable current resulting in a muscle response.
71
The optimal distance to advance a perineural catheter past the needle tip remains unknown, but there are data to suggest that increasing the insertion distance is correlated with an increased risk of catheter coiling, and possibly the final nerve-to-catheter tip distance. 36, [72] [73] [74] Considering the multiple catheter knots reported with insertion Ͼ5 cm, [75] [76] [77] [78] and the lack of data suggesting insertion lengths Ͼ5 cm is beneficial, recommending a maximal insertion of 5 cm seems warranted. 66 Recently reported "self-coiling catheters" may render this issue moot in the future if they are found reliable and approved for human use. 79 Similarly, the optimal minimum insertion distance remains unknown, with evidence that 0 to 1 cm results in a minimal risk of secondary block failure, 33, 80 but possibly an increased risk of subsequent dislodgement. 81 
CATHETER INSERTION (ULTRASOUND)
Unfortunately, data from controlled trials involving electrical stimulation-guided catheter insertion, or even ultrasound-guided single-injection blocks, is not automatically applicable to ultrasound-guided catheter insertion for multiple reasons. Although the limited length of this review article precludes an in-depth discussion of these issues, the information is available elsewhere. 82 Whereas many relatively large series demonstrate the feasibility of ultrasound-guided catheter insertion, [83] [84] [85] [86] there are currently few RCTs to help guide practice. 87 One study suggests that for infraclavicular catheters, there is little difference in the surgical block resulting from a bolus of local anesthetic injected via the needle before catheter insertion compared with the catheter after needle removal. 88 Another RCT demonstrates the difficulty and poorer success rate of inserting a catheter with the longitudinal plane of the needle parallel to the femoral nerve compared with a perpendicular orientation. 89 Lastly, a recent publication suggests that for interscalene catheters, a needle with its long axis parallel to the nerve has distinct benefits compared with a perpendicular needle-to-nerve orientation.
90
Because of the multiple variables for various blocks/ techniques (e.g., bolus via the catheter versus needle, catheter insertion distance, and catheter design), applying the results of one study to others' practices will most likely prove difficult. 82 For example, the results of the abovementioned infraclavicular catheter study will probably not be replicated with a single catheter injection of local anesthetic via a popliteal sciatic catheter because of differences in perineural anatomy between the 2 sites. 91 Similarly, in the RCT comparing anterolateral and posterior approaches, 90 a relatively rigid 3-orifice catheter was used, greatly increasing the chance that for the posterior approach all 3 orifices would fail to reside within the narrow facial (anterior-posterior) plane containing the brachial plexus. 92 Evidence from other investigations suggests that the posterior approach is highly reliable using a relatively flexible single-orifice catheter, 62, 93 and that using a flexible catheter for other needle in-plane approaches may help avoid the catheter tip bypassing the target nerve during insertion. 74, 81 Simply visualizing the catheter tip in close relation to the target nerve intuitively seems to be an obvious solution; however, in practice, identifying the tip is often challenging because, unlike rigid needles, flexible catheters do not usually remain within the ultrasound plane of view. Although there are exceptions, 94,95 many investigators observe the location of fluid, 96 an agitated fluid/air mixture, 97 or simply air 98,99 injected through the catheter. Unfortunately, the positive and negative predictive value of each of these methods remains unknown, and even what constitutes a "positive" or "negative" test has yet to be determined. Future technological developments in equipment such as 3-dimensional ultrasound may render this issue moot.
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NERVE STIMULATION VERSUS ULTRASOUND GUIDANCE
Many RCTs suggest that for most anatomic locations, catheters inserted with ultrasound guidance provide at least similar analgesia, and often decrease insertion-related discomfort and insertion time, compared with an electrical technique using an insulated needle and nonstimulating [101] [102] [103] 120 -122 There are also situations, such as when placing a posterior lumbar plexus catheter, whereby prepuncture ultrasound visualization may aid subsequent electrical stimulation-guided catheter insertion. 123 Lastly, the relative costs of each insertion modality must be accounted for, with 1 investigation suggesting that for single-injection peripheral nerve blocks, the use of ultrasound guidance is at least as financially competitive, and often becomes a "profit center," depending on the clinical scenario, compared with electrical stimulation.
124
INFUSATES
Local anesthetic is the primary analgesic infused during CPNB. Although intermediate-duration drugs may be used, 125,126 the most frequently reported drugs are ropivacaine, bupivacaine, and levobupivacaine because of their longer duration of action and favorable sensory:motor block ratio.
127 Because the precise equipotency ratios of perineural local anesthetics remain unknown, comparisons are problematic. 128 Although the available data suggest bupivacaine and levobupivacaine have higher potency than ropivacaine, 129,130 all 3 provide similar analgesia within human trials. However, the ropivacaine concentration is often increased up to 50% to compensate for decreased potency. 20,129 -134 One study of interscalene infusion provides evidence that ropivacaine 0.2% induces fewer finger paresthesias and less hand weakness than bupivacaine 0.15%. 133 However, similar investigations using different concentrations of levobupivacaine and ropivacaine suggest that any differences in the induced motor block are minimal as long as the ropivacaine concentration is increased by approximately 50%. 129 -132 Conversely, there are data to suggest that when the perineural infusion is discontinued, the sensory and motor effects of bupivacaine greatly outlast those of ropivacaine. 133 This may be relevant when titration of local anesthetic to limit undesired effects is needed (e.g., femoral perineural infusion-induced quadriceps femoris weakness limiting ambulation, or an insensate extremity during infraclavicular or popliteal sciatic infusion). Of note, data derived from laboratory animals suggest that both ropivacaine and bupivacaine induce tissue injury, 135, 136 but ropivacaine results in significantly less damage. 137, 138 The clinical implications of these data remain unknown.
It also remains unknown whether the primary determinant of CPNB effects is solely local anesthetic dose (mass), 129, 131, 139, 140 or if volume (rate) and/or concentration exert additional influence. For single-injection nerve blocks, volume and concentration primarily determine efficacy when dose is held constant. 141, 142 However, for continuous blocks, data from the only study that varied both the infusion rate and concentration in a static ratio so that the total dose was comparable in each treatment group suggest that local anesthetic concentration does not influence block effects as long as the total dose remains constant. 143 Unfortunately, the results from this study of posterior lumbar plexus ropivacaine infusion may not be applicable to other anatomic locations, 140 147 and thus further investigation is required for a definitive answer.
To complicate the issue, in the clinical setting, patientcontrolled bolus doses and/or an adjustable basal infusion rate are often provided, and therefore total local anesthetic dose varies depending on individual patient requirements. 57,129,144 -146,151,152 In these clinical cases, it seems that concentration and rate do influence infusion effects. 145, 146, 151 Unfortunately, currently published studies provide widely conflicting data, probably because of the many variables influencing infusion effects and analgesic requirements.
129, 144 -146,151-153 For example, studies involving interscalene ropivacaine infusion report increasing local anesthetic concentration results in increased, 129 decreased, 144 or no 152, 153 difference in postoperative analgesia. Similarly, increasing local anesthetic concentration has differing effects on the incidence of an insensate extremity depending on catheter site location: increased for infraclavicular, 145 decreased for popliteal, 146 no difference for axillary, 153 and variable for interscalene. 139, 144, 152 Therefore, no optimal concentration/rate combination may be recommended for all anatomic locations, and further study is warranted. For bupivacaine/levobupivacaine and ropivacaine, the most frequently cited concentrations are between 0.1% to 0.125% and 0.1% to 0.2%, respectively.
Several medications are occasionally added to the local anesthetic during CPNB in an attempt to improve analgesia without increasing motor block. There are reports of the inclusion of opioid with perineural local anesthetic, 147, 154, 155 but currently there are insufficient data to draw any conclusions regarding its efficacy. 156, 157 Although clonidine was often added in the earlier years of CPNB, 147,154,158 -161 3 subsequent RCTs failed to demonstrate any clinically relevant benefits. 65, 162, 163 An additional RCT found no benefit to adding epinephrine to perineural ropivacaine, 164 and possible prolonged vasoconstriction places the safety of this practice into doubt. 8, [165] [166] [167] Additional possible adjuvants have been reported, but none is currently approved for perineural use in patients, 168, 169 and some may have unacceptable systemic effects. 169 
LOCAL ANESTHETIC DELIVERY REGIMENS
Infusates may be administered with 3 main strategies: exclusively as a basal infusion or bolus dose, and a combination of these 2 modalities. Unfortunately, similar to the data involving local anesthetic concentration, studies of delivery strategy are somewhat mixed (Table 2) . 170, 171 In general, RCTs involving femoral and fascia iliaca infusions have reported few differences in analgesia among the various delivery regimens (other than reduced local anesthetic use with bolus-only dosing). 154, 158, 172 Conversely, for sciatic catheters, providing a basal infusion maximizes analgesia and other benefits, 170, 171 although the data regarding the benefits of adding patient-controlled bolus doses are less clear. 170, 171, 173 Interestingly, providing automated, hourly, 5-mL bolus doses of levobupivacaine via a popliteal sciatic catheter decreased pain scores compared with patients receiving a continuous, 5-mL basal infusion of 0.125% levobupivacaine 174 (although a similar investigation involving femoral ropivacaine infusion failed to detect differences in sensory or motor effects). 94 However, by adding patient-controlled bolus doses to these 2 regimens, the difference in pain scores disappeared. 175 Importantly, all investigations report less total consumption of local anesthetic with regimens providing patient-controlled bolus doses, suggesting the desirability of including this modality for 3 main reasons: (1) decreasing the required basal infusion rate and thus theoretically decreasing motor block (inadequately investigated to date) 94, 133, 176 ; (2) decreasing the incidence of an insensate extremity 31 ; and (3) increasing the duration of infusion/analgesia for ambulatory patients discharged with a finite volume of local anesthetic. 170, 177 In contrast to the lower extremity, investigations of interscalene 147 and infraclavicular 57 perineural infusion are more uniform and suggest that including a basal infusion improves baseline analgesia, decreases the incidence and severity of breakthrough pain, and decreases sleep disturbances and supplemental analgesic requirements. Furthermore, adding patient-controlled bolus doses to a basal infusion decreases total local anesthetic consumption and supplemental analgesic requirements, 57,147,173 allows block reinforcement during dressing changes or physical therapy, 147, 178, 179 and may provide increased independent activity. 173 Additional RCTs attempting to further refine interscalene dosing report somewhat conflicting results. One study provides evidence that a high basal rate combined with low-volume, patient-controlled bolus doses reduces baseline pain scores and sleep disturbances, and decreases the incidence and severity of breakthrough pain, but at a cost of increasing local anesthetic consumption. 67 However, other similar investigations report few differences in varying the basal infusion rate. 140, 173, 180 Unfortunately, because of the heterogenicity of catheter types, insertion techniques, and a myriad of additional factors, there is little evidence for an "optimal" infusion regimen. Until recommendations based on prospectively collected data are available, health care providers may wish REVIEW ARTICLE Table 2 to consider that most published investigations report a basal rate of 4 to 10 mL/h (lower rates for catheters of the lower extremity; higher rates for the upper extremity), a bolus volume of 2 to 10 mL, and a bolus lockout period of 20 to 60 minutes. Similarly, the maximum recommended hourly total dose of local anesthetic during perineural infusion remains unknown, 181 but a wide safety margin has been documented in numerous clinical trials, 125, 140, 148, [182] [183] [184] [185] [186] [187] with 1 study reporting no toxicity signs or symptoms with perineural ropivacaine 0.2% administered at basal rates up to 14 mL/h and large, repeated boluses of ropivacaine 0.5% (10 -60 mL) provided for up to 27 days. 188 
INFUSION PUMPS
Although perineural local anesthetic may be provided using exclusively human-administered bolus doses, 189 both clinical factors (e.g., basal infusion benefits) as well as logistical considerations 190 usually dictate the use of an infusion pump. There is no single optimal device for all situations, given the multitude of clinical scenarios and practice requirements, so pump preference is usually based on the desired device characteristics. 191 Infusion pumps may be (arbitrarily) categorized by their power source. Although spring-and vacuum-powered devices are available, neither is particularly desirable for the purpose of CPNB because of a multitude of factors, including highly variable basal infusion rates and relatively small local anesthetic reservoir volumes, respectively. 192, 193 Until recently, elastomeric infusion pumps were severely limited relative to the capabilities of electronic devices 190 ; however, with the advent of newer nonelectronic pumps, this is no longer the case.
In general, electronic devices provide very accurate and consistent (Ϯ5%) basal infusion rates over the entire course of infusion. [192] [193] [194] [195] In contrast, elastomeric pumps usually overinfuse (110%-130% expected) during the initial 3 to 8 hours of infusion and within the final hours before reservoir exhaustion, [192] [193] [194] [195] [196] resulting in a shorter infusion duration than anticipated given the initial reservoir volume and set basal infusion rate. [192] [193] [194] [195] 197, 198 However, whether the increased variability is clinically significant, or in which clinical situations it is relevant, remains unknown. Unlike electronic devices, the basal infusion rate of most elastomeric devices increases with increasing ambient temperature and pump height relative to the catheter insertion site, [192] [193] [194] [195] 198 although these changes are probably clinically relevant only at extreme values.
An adjustable basal infusion rate allows local anesthetic administration titration in case of an insensate extremity, 31 undesired side effects (e.g., muscle weakness), 94, 180 inadequate analgesia, 170 or desire to maximize infusion duration (e.g., ambulatory patients with a set reservoir volume). 57, 170, 177 In addition, a patient-controlled bolus function often provides many clinical benefits. 57, 147 All electronic pumps provide an adjustable basal rate, patient-controlled bolus doses, and a variable bolus lockout period. [192] [193] [194] [195] Although most elastomeric devices provide a fixed basal infusion rate, 191 a few now provide flexibility similar to their electronic counterparts. Nearly all electronic pumps use an external local anesthetic reservoir that allows for easy reservoir exchanges. 116, 188 In contrast, all elastomeric devices have an internal reservoir. Even though refilling such devices has been investigated, 199, 200 this procedure is not approved by manufacturers/governments for the majority of devices, requiring the use of an additional unit if continued infusion is desired after reservoir exhaustion. 173, [201] [202] [203] Regardless of reservoir type, filling the infusion pump/reservoir within the United States must now be executed within an isolation class 5 environment, essentially requiring local anesthetic compounding within a designated pharmacy with a laminar flow workbench. 204 Nonelectronic infusion pumps are often favored for their relative simplicity in both initially setting and subsequently adjusting the basal infusion rate 205 ; for their light weight and smaller size 206 ; their lack of audible alarms 206, 207 (although there is no warning for a pause in the infusion) 208 ; disposability 209 ; and for their silent operation (noise generated by electronic pumps may disturb patient sleep). 206 In addition, elastomeric devices with a manufacturer-fixed basal rate and no bolus dose capability are usually relatively inexpensive. 191 Conversely, reusable electronic pumps use inexpensive disposable "cassettes" to provide sterile infusion for individual patients. 177 A limited number of single-use electronic devices are available. 144 -146 Lastly, although the reliability for most infusion pumps is high, regardless of power source, certain devices are more dependable than others for both electronic 207,210 -213 and nonelectronic pumps.
196,208
AMBULATORY PERINEURAL INFUSION
First described in 1997, 214 CPNB may be provided to patients outside of the hospital using a portable infusion pump, and nearly every catheter type (i.e., anatomic location) has been reported in ambulatory patients. 191 Perineural infusion is often provided for ambulatory surgery without an overnight hospital stay, 84 -86 but the technique may be used to shorten hospitalization 178, 215 and/or provide benefits after discharge either home or to a skilled nursing facility. 33, 200 Time constraints are often more restrictive in high-turnover ambulatory centers, 85 making insertion techniques with documented time savings frequently desirable (e.g., ultrasound guidance).
61,64,105,216 Because patients are rarely directly monitored outside of the hospital, and not all patients desire or are capable of accepting the additional responsibility of caring for the catheter and pump system, patient selection criteria are often more stringent for ambulatory CPNB. In an effort to avoid local anesthetic toxicity, patients with renal or hepatic insufficiency are often excluded from outpatient perineural infusion. 182 For infusions possibly affecting the phrenic nerve and weakening the ipsilateral diaphragm (e.g., interscalene and paravertebral catheters), [217] [218] [219] caution is warranted for individuals with heart/lung disease and in obese patients who may not be able to compensate for mild hypoxia and/or hypercarbia. 220, 221 Of note, age alone is not an absolute exclusion criterion, with hundreds of pediatric patients receiving at-home CPNB without complication rates or severity higher than for their adult counterparts. 14,24 -26 Providing ambulatory CPNB often leads to a reduced time until discharge readiness 33, 58, 178, 222 and, in some cases, actual discharge. 178, 215 After tricompartmental knee arthroplasty, permitting early discharge with ambulatory femoral infusion results in decreased hospitalization-related costs. 223 However, although ambulatory continuous femoral and posterior lumbar plexus nerve blocks decrease the time until important discharge criteria are met, 33,58,222 an increased incidence of patient falls in patients receiving ropivacaine versus saline through their catheters suggests that increased caution is warranted before implementing early discharge. 176 Nevertheless, relatively small published series demonstrate the feasibility of total joint arthroplasty with only a singlenight hospital stay, or even on an outpatient basis, when patients are permitted to continue their hospital-based perineural infusion at home. 84, 202, 203, 224, 225 Although the benefits of home CPNB are well documented with many placebo-controlled RCTs, 31, 33, 34, 58, 93, 178, 222, 226, 227 there are negligible published data regarding the optimal practice for multiple aspects of ambulatory infusion, such as the requirement of a patient caretaker 86 ; method/frequency of patient oversight (e.g., home nursing visits, 173, 228, 229 telephone calls, 20, 205 or simply written instructions with solely patient-initiated contact); and catheter removal protocol (health care provider extraction, 173, 229 caretaker withdrawal with instructions provided by telephone, 222 or simply written instructions 226 ). Of 40 patients with a hospitalbased CPNB, 13% stated they would be unwilling to remove their catheter at home. 230 However, of patients who previously removed a perineural catheter at home, 98% felt "comfortable" doing the procedure with instructions given by telephone, only 4% would have preferred to return to the hospital for health care provider catheter removal, and 43% would have felt comfortable with exclusively written instructions. 205 Of note, at least within the United States, there are no national guidelines regarding the maximal safe CPNB duration. 204 
BENEFITS OF CPNB
Whereas case reports and series suggest numerous possible benefits of CPNB for a wide variety of ailments, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] published RCTs include exclusively postoperative patients. Providing analgesia is the primary indication for postoperative CPNB, 18 and most CPNB benefits seem to be dependent on successfully improving pain control (Table  3) . 18 Potent analgesia is most dramatic for surgical sites that are completely innervated by nerves affected by the perineural infusion, as is often the case for shoulder and foot procedures (interscalene and sciatic perineural catheters, respectively). 31, 34, 93, 178, 215, 226, 230 Unfortunately, brachial plexus infusions for procedures at or distal to the elbow seem to provide less-impressive analgesia, 227 even though they (theoretically) cover the entire surgical site. RCT-documented benefits of axillary, 153 supraclavicular, [231] [232] [233] and transversus abdominus plane 234 infusion are severely lacking. Although the benefits of infraclavicular infusion are validated, 227 analgesia is often less than optimal unless a high enough dose of local anesthetic is administered, frequently rendering the extremity insensate.
57,145
Similarly, femoral or posterior lumbar plexus infusion may result in unacceptable quadriceps femoris and hip adductor weakness when a high enough dose of local anesthetic is administered to optimize analgesia. 94 In addition, a single perineural infusion for surgical sites innervated by multiple nerves, most notably the hip, knee, and ankle, may provide less than optimal analgesia without the concurrent use of additional analgesics. 33, 58, 146 Of published reports, nearly all investigators provide a single infusion, often supplemented with a separate single-injection peripheral nerve block (e.g., sciatic block after knee surgery). 235 Some individuals have proposed inserting a second catheter, 236 -238 although there are minimal and somewhat conflicting data to guide clinical practice. 239, 240 Whereas a lumbar epidural provides generally equivalent analgesia to femoral perineural infusion for hip and knee arthroplasty, CPNB results in a more favorable side-effect profile without the risk of epidural hematoma during concomitant anticoagulant administration. 159, 161, 241, 242 Although the evidence for CPNB benefits during local anesthetic infusion is overwhelming, there are few data demonstrating benefits after catheter removal. Exceptions include improved analgesia after a few days 2,32,243 or 6 months 240 ; more rapid resumption of unassisted standing and lavatory use 2 ; increased health-related quality of life in 1 study 244 (but not 5 others) [245] [246] [247] [248] [249] ; and faster tolerance of passive knee flexion 2 resulting in earlier discharge from rehabilitation centers. 159, 161 Conspicuously lacking is evidence of medium-or long-term improvements in healthrelated quality-of-life measures.
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COMPLICATIONS
As with all medical procedures, the potential CPNB benefits must be weighed against the potential risks. Fortunately, infusion-related serious and lasting injuries are uncommon, whereas relatively minor complications occur at a frequency similar to single-injection peripheral nerve blocks. 251 Unfortunately, heterogeneous catheter insertion techniques, equipment, anatomic locations, and infusions render generalizations difficult. For example, various prospective studies report an incidence of secondary block (infusion) failure of 1%, 252 20%, 34 and 50%. 36 Thus, the specific complication rates provided in this section will not apply to all practices. CPNB-specific complications during catheter insertion include inaccurate catheter tip placement too far from the target nerve to provide postoperative analgesia, 35 and in exceptionally rare cases, epidural, [253] [254] [255] intrathecal, 256 -258 intravascular, 227, 259 intraneural, 260 and even interpleural catheter insertion. 261 Catheter migration after accurate placement has been suggested, 262 but also doubted, 263 and the dearth of published events suggests that it is an exceptionally rare event, if it even occurs at all.
During the perineural infusion, more common (and benign) complications include catheter dislodgement or obstruction 116, 173, 252 and fluid leakage at the catheter site. 173, 227 Although not prospectively investigated, subcutaneous catheter tunneling, 41,264 application of liquid adhesive, 191 use of a catheter anchoring device, 191 and applying 2-octyl cyanoacrylate glue 265 may decrease the incidence of dislodgement and leakage.
Additional possible complications include infusion pump malfunction, 207 ,266 undesired pause, 208 or disconnection 33 ; skin irritation or allergic reactions to the catheter dressing and/or liquid adhesive 267 ; and catheter-induced brachial plexus irritation. 268 In addition, a CPNB-induced insensate extremity may prove disconcerting to patients, 269 impede 238 Mistraletti et al., 237 and Blumenthal et al. 240 compared 2 concurrent continuous peripheral nerve blocks versus no regional intervention, and therefore one or both of these anatomic catheter locations may account for all of the difference between treatment groups.
Continuous Peripheral Nerve Blocks: A Review of the Published Evidence
October 2011 • Volume 113 • Number 4 physical therapy and/or ambulation, 133, 222 and be considered a risk factor for injury by some investigators. 145, 146 In these cases, the infusion pump is usually paused until sensory perception begins to return, after which the infusion is restarted at a lower basal rate.
31,58 Conversely, inadequate analgesia or breakthrough pain may occur, and is often treated by increasing the basal infusion and providing patient-controlled bolus doses, respectively.
31,227
More serious (but very rare) complications include myonecrosis with repeated large boluses of bupivacaine 270 278 Although infusions potentially affecting the phrenic nerve may have minimal pulmonary effects for relatively healthy patients, 155, 217, 279 dyspnea is somewhat common, 67 and lower lobe collapse has occurred. 221 There is limited evidence that the risk of nerve injury from prolonged local anesthetic exposure may be increased in patients with diabetes 280, 281 and/or preexisting neuropathy. 282 There are case reports of peri-catheter hematoma formation, 276, 283 often with concurrently administered lowmolecular-weight heparin for thromboprophylaxis. 284 -286 Most are self-limiting, 285 but more dramatic cases require surgical evacuation. 283 The most recent (Third) American Society of Regional Anesthesia consensus statement on neuraxial anesthesia and anticoagulation explicitly recommends precautions for neuraxial techniques and that anticoagulation be exercised for "deep" perineural catheters (undefined); specifically, that any catheter be removed before administration of various anticoagulants, 287 although this practice has been questioned by various investigators. 288 -293 Also concerning is the association between perineural infusions affecting the femoral nerve and patient falls after hip and knee arthroplasty, 176 possibly because of CPNB-induced sensory, proprioception, and/or quadriceps weakness. 94 Correlation does not prove causation; however, until further evidence is published, practitioners should consider interventions that may decrease the risk of falls, such as limiting the local anesthetic dose/mass 143 ; providing crutches/walker and a knee immobilizer during ambulation 294 ; and educating surgeons, nurses, and physical therapists of possible CPNB-induced deficits and fall precautions.
Although the reported rates of inflammation (3%-4%) 252, 266, 295 and catheter bacterial colonization (6%-57%) are seemingly high, 296, 297 clinically relevant infection is relatively rare (incidence 0%-3% 298, 299 ; but most reports Ͻ1%).
38,126,251,296,300 Risk factors include admission to an intensive care unit, absence of perioperative antibiotic prophylaxis, and male sex. 266 Although 1 multicenter study found a higher risk with axillary and femoral catheters, 266 others have reported the interscalene location as the most problematic. 252, 299 Risk of infection is also correlated with infusion duration. 266 Nonetheless, infusions provided during extended medical transport for up to 34 days 116 and provided at home for up to 83 days 200 have been reported with a minimal incidence of infection. There is limited evidence that subcutaneous catheter tunneling 264 may decrease the risk of bacterial colonization and infection. 296 Abscesses have occurred, although the incidence remains unknown, and occasionally require surgical treatment, 301 but often do not if timely antibiotic coverage is provided. [302] [303] [304] Although life-threatening catheter-related infections/sepsis have been reported, 305, 306 there is currently no case of permanent injury due to CPNB-related infection within the English-language literature. 298 Perhaps the most feared postinfusion complication is neurologic injury. 307 It is often difficult to determine how much of a neurologic deficit, if any, is attributable to CPNB because all surgical procedures are associated with a variable incidence of nerve injury, 308 regardless of the application of a regional anesthetic/analgesic. 309, 310 For example, hip arthroplasty without a regional anesthetic is associated with an incidence of femoral neuropathy as high as 2.3%. 310 So, if a study with a regional anesthetic/analgesic in this same patient population found a 1% incidence of femoral neuropathy, it would suggest that the perineural infusion is actually protective; but such an uncontrolled study would seem alarming with such a high incidence of nerve injury "associated" with CPNB. With this critical limitation in mind, the incidence of transient adverse neurologic symptoms associated with CPNB is 0% to 1.4% for interscalene, 38, 251, 252, 266, 276 0.4% to 0.5% for femoral, 266, 276 and 0% to 1.0% for sciatic catheters. 252, 266, 272, 276 An additional investigation found a 0.2% incidence of neurologic deficits lasting longer than 6 weeks in nearly 3500 catheters from multiple anatomic locations. 252 In this latter study, it remains unknown whether the deficits resolved after the 6-week study period, but multiple prospective investigations report that the overwhelming majority of neurologic symptoms present at 4 to 6 weeks resolve spontaneously within 3 months of surgery. 38, 251, 266 There are reported cases of long-term and/or permanent nerve injury in patients with perineural infusion. 311 Five large, prospective series 38,251,266,272,276 that followed patients for at least 3 months found 3 cases of unresolved adverse neurologic events: a brachial plexus lesion after interscalene infusion (followed 9 months) 251 ; a femoral neuropathy presumably the result of a retroperitoneal hematoma (cause undetermined; months followed not reported) 276 ; and a persistent paraesthesia after a popliteal sciatic catheter (followed through 18 months). 272 Combining the results of these studies (4148 subjects) suggests that the risk of neurologic injury lasting longer than 9 months associated with CPNB is 0.07%. 38, 251, 266, 272, 276 It remains unknown whether CPNB contributed to these cases, or if they would have occured without the addition of a regional analgesic. Although ultrasound guidance may decrease the incidence of many/most of these reported complications, 312 there are few data supporting this proposition, 313, 314 and case reports suggest that completely abolishing such events is unlikely (quite possibly because postoperative neuropathy may occur without any regional anesthetic/analgesic).
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CONCLUSIONS
Although the published literature presented in this review article provides a plethora of information involving CPNB, many aspects of perineural infusion have yet to be fully elucidated, including the optimal catheter insertion modality and technique; infusate(s) and adjuvants; local anesthetic delivery regimen; details of optimizing ambulatory infusion; possible infusion benefits; and the incidence of all possible risks. Furthermore, although CPNB seems to provide far more potent analgesia than wound catheters, 318 -320 and often fewer undesirable side effects than epidural infusion, 23,159,161,242,318 many questions remain regarding the optimal analgesic technique for many surgical procedures. 321, 322 Lastly, perineural infusion must be adequately compared with possible new analgesic techniques. 244, 323 Only through prospective research will we fully reveal and maximize the potential benefits, while minimizing the potential risks, of CPNB for our patients. 
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